A Phase 1, Multicenter, Open Label, Dose Escalating, Saf

  • Cooley, Sarah A, (PI)

Project: Research project

Project Details

Description

A Phase 1, Multicenter, Open Label, Dose Escalating, Safety Study of Human Umbilical Cord Blood Derived, Culture Expanded, Natural Killer Cell (PNK-007) Infusion
StatusActive
Effective start/end date12/1/1512/31/20

Funding

  • Celgene Corporation

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.